Literature DB >> 15046278

Congenital chylothorax: lymphopenia and high risk of neonatal infections.

A Wasmuth-Pietzuch1, M Hansmann, P Bartmann, A Heep.   

Abstract

AIM: To describe the clinical course of patients with congenital chylothorax focusing on infectious complications. Congenital chylothorax is a common manifestation of non-immune hydrops fetalis (NIHF). The drainage of chyle leads to loss of cellular and plasmatic factors that influence the patient's immune response and increase the risk of infections.
METHODS: In a retrospective analysis of 24 preterm infants with NIHF treated between 1998 and 2002, congenital chylothorax was diagnosed in 7 patients.
RESULTS: All 7 patients were treated conservatively with pleural drainage over a median period of 22 d (range 10-36 d). Lymphopenia was found in all patients (median of minimal lymphocyte counts 285/microl, range 80-770). The nadir was on day 5 (2-6 d). Lymphopenia lasted for 12 d median (range 4-39 d) and was significantly correlated with the duration of lymph drainage (p = 0.001). Cell-surface analysis of peripheral blood lymphocytes was performed in two patients. Both patients had a decreased number of total T cells. Four out of seven (57%) patients developed nosocomial infections. This incidence of nosocomial infections in patients with congenital chylothorax is about three times higher than that in other neonatal patients. None of the children suffered from fungal or viral infection. Although there was a very high incidence of infections, no correlation between lymphopenia and the occurrence of infections could be shown.
CONCLUSION: Drainage of congenital chylothorax results in the loss of lymphocytes and bears a high risk of infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046278     DOI: 10.1080/08035250310007312

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  19 in total

Review 1.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

Review 2.  Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters.

Authors:  Erik Vakil; Carlos A Jimenez; Saadia A Faiz
Journal:  Curr Opin Pulm Med       Date:  2018-07       Impact factor: 3.155

Review 3.  [Therapy management of chylothorax].

Authors:  S Bölükbas; N Kudelin; T Dönges; J Schirren
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

4.  Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy.

Authors:  Takeo Fujita; Hiroyuki Daiko
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

5.  Impact of chylothorax on the early post operative outcome after pediatric cardiovascular surgery.

Authors:  Sameh R Ismail; Mohamed S Kabbani; Hani K Najm; Ghassan A Shaath; Abdulraouf M Z Jijeh; Omar M Hijazi
Journal:  J Saudi Heart Assoc       Date:  2014-01-13

6.  Chylothorax after blunt trauma.

Authors:  Eric Seitelman; Jason J Arellano; Kazuaki Takabe; Leonard Barrett; Glenn Faust; L D George Angus
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

7.  Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion.

Authors:  Jeong Eun Kim; Chul Lee; Kook In Park; Min Soo Park; Ran Namgung; In Kyu Park
Journal:  Korean J Pediatr       Date:  2012-05-21

8.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 9.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

Review 10.  Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis.

Authors:  Michael Kranzfelder; Ralf Gertler; Alexander Hapfelmeier; Helmut Friess; Marcus Feith
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.